​

Aligos Therapeutics (ALGS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Aligos Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$27.78M

Aligos Therapeutics Revenue by Period

Aligos Therapeutics Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$3.94M-74.60%
2023-12-31$15.53M11.66%
2022-12-31$13.91M219.04%
2021-12-31$4.36M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Aligos Therapeutics generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Aligos Therapeutics Revenue by Quarter

DateRevenueChange
2026-06-30$27.78M881.55%
2026-03-31$2.83M1574.56%
2025-12-31$169.00K-77.19%
2025-09-30$741.00K-23.21%
2025-06-30$965.00K210.29%
2025-03-31$311.00K-50.56%
2024-12-31$629.00K-50.43%
2024-09-30$1.27M19.60%
2024-06-30$1.06M7.61%
2024-03-31$986.00K-63.22%
2023-12-31$2.68M-17.23%
2023-09-30$3.24M-52.96%
2023-06-30$6.89M152.88%
2023-03-31$2.72M-23.01%
2022-12-31$3.54M-13.86%
2022-09-30$4.11M11.18%
2022-06-30$3.69M43.64%
2022-03-31$2.57M600.54%
2021-12-31$367.00K-76.12%
2021-09-30$1.54M-0.52%
2021-06-30$1.54M69.78%
2021-03-31$910.00K100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-06-30-100.00%
2018-03-31--

Aligos Therapeutics generated $27.78M in revenue during Q2 2026, up 881.55% compared to the previous quarter, and up 8931.83% compared to the same period a year ago.

Aligos Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MRSNMersana Therapeutics$40.50M$11.01M
XFORX4 Pharmaceuticals$35.11M$8.81M
FGENFibroGen$6.44M$-1.47M
INMBINmune Bio$14.00K-
OKUROnKure Therapeutics--
BRNSBarinthus Biotherapeutics--
ALGSAligos Therapeutics-$27.78M
SKYESkye Bioscience--
TPSTTempest Therapeutics--

ALGS Revenue FAQ

What is Aligos Therapeutics’s yearly revenue?

Aligos Therapeutics's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $3.94M, representing a decrease of -74.60% compared to 2023. ALGS's yearly revenue for 2023 was $15.53M, representing an increase of 11.66% compared to 2022.

What is Aligos Therapeutics’s quarterly revenue?

Aligos Therapeutics's quarterly revenue for Q2 2026 was $27.78M, a 881.55% increase from the previous quarter (Q1 2026), and a 2778.55% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $2.83M, a 1574.56% increase from the previous quarter (Q4 2025), and a 809.97% increase year-over-year (Q1 2025). ALGS's quarterly revenue for Q4 2025 was $169K, a -77.19% decrease from the previous quarter (Q3 2025), and a -73.13% decrease year-over-year (Q4 2024).

What is Aligos Therapeutics’s revenue growth rate?

Aligos Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was -100.00%.